'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. White House responds to Pope Leo’s rebuke of Trump peace plan for Ukraine After winning his ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

“Paddy Power has had a hugely positive impact on the World Darts Championship over the past two years,” said PDC Chief Executive Matt Porter once the news was announced. “Their creativity, investment ...

The Chicago Bears finally got a win over a team over .500 on Sunday. Barely, of course. The Bears have built an 8-3 record, which is fantastic, but they have done particularly well in two areas: ...

Purchasing power reflects how much can be bought with a set amount of money over time. Inflation reduces purchasing power, meaning money buys less due to rising prices. To outpace inflation, ...

Getting good at LeetCode Java can feel like a puzzle sometimes, right? You see all these problems, and you’re not sure where ...